Latest Ketorolac Stories
ATLANTA, Jan. 14, 2015 /PRNewswire/ -- Alimera Sciences, Inc.
-- New nonsteroidal anti-inflammatory drug (NSAID) medication used for management of mild to severe pain in adults -- LAKE FOREST, Ill., Dec.
ATLANTA, Nov. 17, 2014 /PRNewswire/ -- Alimera Sciences, Inc.
-- Unique Billing Code Allows Separate Payment for Omidria -- SEATTLE, Oct.
TARRYTOWN, N.Y., Oct. 17, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
On October 6, the FDA announced that three lots of Ketorolac Tromethamine Injection, USP, 30mg/mL single-dose vials, distributed by Sagent, are recalled due to incorrect labeling.
CEO to Discuss Milestone FDA Approval of ILUVIEN as the First Long-Term Treatment for Diabetic Macular Edema ATLANTA, Oct. 9, 2014 /PRNewswire/ -- Alimera Sciences, Inc.
Company will issue a more detailed announcement on Monday, September 29 ATLANTA, Sept. 26, 2014 /PRNewswire/ -- Alimera Sciences, Inc.
MISSISSAUGA, ON, Sept. 8, 2014 /PRNewswire/ - Nuvo Research Inc.
Sweden is latest country to grant marketing authorization ATLANTA, Sept. 3, 2014 /PRNewswire/ -- Alimera Sciences, Inc.
- An imitative word; an onomatopoetic word.